#United States #Birmingham #RxBenefits #Pharmacy Benefits #Specialty Drugs

RxBenefits Launches Q1 2026 Pharmacy Benefits Market Report

On May 14, 2026, RXBenefits, Inc. announced the release of its latest market report, titled "An Industry in Flux: How to Navigate the Complex Pharmacy Benefits Landscape with Confidence." This inaugural report is part of a series aimed at equipping employee benefits advisors with the information they need to maneuver through the rapidly changing pharmacy benefits management (PBM) market. It also provides essential support for self-funded employers looking for sustainable cost savings.

Major Findings and Legislative Changes

The report highlights significant legislative and regulatory changes that are reshaping pharmacy benefits. Among these, it delves into federal reforms, particularly the impact of the Consolidated Appropriations Act of 2026, as well as state-level regulations that are increasing compliance demands. By addressing these updates, RxBenefits aims to guide benefits advisors in managing the overlapping compliance requirements and heightened fiduciary responsibilities faced by self-funded employer clients.

PBM Pricing Models Analyzed

Additionally, RxBenefits' report investigates both traditional and innovative pricing strategies currently available in the PBM market. It contrasts older spread-based models with newer transparent models, including modular options that utilize cost-plus networks. The analysis aims to assist advisors in understanding how plan-specific utilization affects pricing strategies, aligning their recommendations with each employer's unique financial goals, improving rebate performance, and enhancing budget predictability.

Specialty Drug Costs & Clinical Management

A crucial highlight from the report is the ongoing pressure on budgets from specialty drug expenses, which now comprise over 55% of a typical plan's annual pharmacy spending, despite being utilized by merely 2% of members. This discrepancy emphasizes the necessity for independent clinical management that operates outside the influence of PBMs' dispensing and rebate revenue. RxBenefits advocates this independent approach to alleviate waste, ensure appropriate utilization, and safeguard health outcomes within the intricate specialty drug arena.

Statements from Leadership

Kyra Hagan, Senior Vice President of Marketing at RxBenefits, remarked, “The pharmacy benefits industry is at a critical turning point, and standing still is not an option for employers or their benefits advisors. This report empowers benefits advisors with the critical insights necessary to help self-funded employers secure long-term savings and deliver high-quality member care, even as the market becomes increasingly complex."

Upcoming Webinar and Further Information

For benefits advisors keen to gain insights on how the latest legislative alterations, innovative pricing frameworks, and transformative solutions are redefining the PBM landscape, RxBenefits is hosting a webinar titled "PBM Disruption in 2026: Tools and Tactics for Benefits Advisors" on May 19 at 11 A.M. CT / 12 P.M. ET. Interested participants can register here.

To explore the full insights provided in the Q1 Market Report, you can access it at rxbene.fit/41WpHHg. For further details about RxBenefits and their comprehensive pharmacy solutions, visit their official website www.rxbenefits.com.

About RxBenefits

RxBenefits is recognized as the nation’s first and only Pharmacy Benefits Optimizer (PBO), specializing in collaboration with benefits advisors and self-funded plan leaders to deliver effective pharmacy solutions. By harnessing extensive marketplace expertise, robust PBM pricing negotiations, independent clinical oversight, and exemplary service, RxBenefits enables organizations to control pharmacy costs while guaranteeing seamless, high-quality care for members. With its headquarters situated in Birmingham, Alabama, RxBenefits supports over 3 million members across the nation.

For media inquiries, reach out to Jill Kipnis at 205-208-8323 or via email at [email protected]